APPENDIX 2
Identifieur interne : 002E77 ( Main/Exploration ); précédent : 002E76; suivant : 002E78APPENDIX 2
Auteurs :Source :
- Transfusion [ 0041-1132 ] ; 2009-08.
English descriptors
- Teeft :
- Aabb, Anaplasma, Anthrax, Applicable impact, Applicable laboratory, Applicable leukoreduction, Assay, Asymptomatic, Asymptomatic viremia, August, Babesia, Babesiosis, Bacteremia, Bacterium, Bartonella, Bioterrorism, Bioterrorism threat, Bioterrorist, Bioterrorist weapon, Blood availability, Blood components, Blood donor screening test, Blood donors, Blood phase, Blood products, Blood safety, Blood supply, Blood transfusion, Borna, Borrelia, Burgdorferi, Cervical, Chaga, Chan, Chikungunya, Chlamydia, Chronic carriage, Clade, Clin, Clin microbiol, Clinical disease, Crosse, Cruzi, Cutaneous, Deferral, Dengue, Derivative, Direct contact, Disease agent, Disease agent characteristics, Disease control, Disease name, Disease symptoms, Disinfectant, Donor, Donor deferral period, Doxycycline, Ebola, Ehrlichia, Emerg, Encephalitis, Encephalopathy, Endemic, Endemic areas, Engl, Enterocolitica, Enterovirus, Epidemiology, Exposure routes, Feces, Fields virology, Formaldehyde, Fractionation process, Fulminant, Genome, Genus, Glutaraldehyde, Hantavirus, Hantaviruses, Helical, Hemorrhagic, Hepatitis, Herpes, Herpesvirus, Howley, Human herpesvirus, Human infection, Hypochlorite, Icosahedral, Icosahedral nucleocapsid symmetry, Immune, Immunocompetent, Immunocompromised, Immunocompromised patients, Inactivating, Inactivation, Incubation, Incubation period, Infection, Infectious diseases, Infectivity, Intracellular, Isoform, Jama, June, Knipe, Lancet, Lassa, Leiby, Leishmania, Leishmaniasis, Length physicochemical properties, Leukoreduction, Lipid, Lipid solvents, Lippincott, Lippincott williams wilkins, Local deferral, Lyme, Lymphadenopathy, Marburg, Meningitis, Microbiol, Microti, Mmwr, Monkeypox, Morb, Mortality rate, Mosquito, Multiple pathogen reduction steps, Mumps, Myalgia, Neonate, Neurologic, Nonenveloped, Nonhuman, Nonhuman primates, Nucleic, Nucleic acid, Nucleocapsid, Orientia, Other prevention measures, Outbreak, Parasitemia, Parenteral, Parvovirus, Pathogen, Pathogen reduction, Peripheral blood, Phagocytophilum, Physicochemical, Physicochemical properties, Plasma derivatives, Plasmodium, Platelet, Pleomorphic, Pneumoniae, Porcine, Potential effectiveness, Primary disease symptoms, Primates, Prion, Priority level, Prowazekii, Prpc, Prpsc, Prudent practice, Public concern, Public perception, Raoult, Rash, Rbc, Reactivation, Relapsing, Retrovirus, Rickettsia, Rickettsial, Robust, Room temperature, Sars, Screening, Secondary transmission, Serologic, Serology, Seropositive, Seroprevalence, Simian, Sodium hypochlorite, Spherical particles, Spongiform, Supplement transfusion, Symptom, Tetracycline, Transfusion, Transfusion transmission, Transfusion volume, Transmission, Transplantation, Trypanosoma, Tsutsugamushi, Uids, Unknown impact, Unknown transmission, Vaccine, Vaccinia, Variola, Vcjd, Viii, Viral, Viremia, Viremic, Virion, Virol, Virology, Virus, Virus infection, Virus isolation, Whole blood, Wilkins, Wkly, Xenotransplantation, Yersinia.
Url:
DOI: 10.1111/j.1537-2995.2009.02281.x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000E47
- to stream Istex, to step Curation: 000E47
- to stream Istex, to step Checkpoint: 000E40
- to stream Main, to step Merge: 002F31
- to stream Main, to step Curation: 002E77
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">APPENDIX 2</title>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:162481915B7934FBCCFFD6340580113709AD18D5</idno>
<date when="2009" year="2009">2009</date>
<idno type="doi">10.1111/j.1537-2995.2009.02281.x</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-TKCPPTW8-N/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000E47</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000E47</idno>
<idno type="wicri:Area/Istex/Curation">000E47</idno>
<idno type="wicri:Area/Istex/Checkpoint">000E40</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000E40</idno>
<idno type="wicri:Area/Main/Merge">002F31</idno>
<idno type="wicri:Area/Main/Curation">002E77</idno>
<idno type="wicri:Area/Main/Exploration">002E77</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">APPENDIX 2</title>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Transfusion</title>
<title level="j" type="sub">Emerging Infectious Disease Agents and their Potential Threat to Transfusion Safety</title>
<title level="j" type="alt">TRANSFUSION</title>
<idno type="ISSN">0041-1132</idno>
<idno type="eISSN">1537-2995</idno>
<imprint><biblScope unit="vol">49</biblScope>
<biblScope unit="issue">s2</biblScope>
<biblScope unit="page" from="45S">45S</biblScope>
<biblScope unit="page" to="233S">233S</biblScope>
<biblScope unit="page-count">189</biblScope>
<publisher>Blackwell Publishing Inc</publisher>
<pubPlace>Malden, USA</pubPlace>
<date type="published" when="2009-08">2009-08</date>
</imprint>
<idno type="ISSN">0041-1132</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0041-1132</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Aabb</term>
<term>Anaplasma</term>
<term>Anthrax</term>
<term>Applicable impact</term>
<term>Applicable laboratory</term>
<term>Applicable leukoreduction</term>
<term>Assay</term>
<term>Asymptomatic</term>
<term>Asymptomatic viremia</term>
<term>August</term>
<term>Babesia</term>
<term>Babesiosis</term>
<term>Bacteremia</term>
<term>Bacterium</term>
<term>Bartonella</term>
<term>Bioterrorism</term>
<term>Bioterrorism threat</term>
<term>Bioterrorist</term>
<term>Bioterrorist weapon</term>
<term>Blood availability</term>
<term>Blood components</term>
<term>Blood donor screening test</term>
<term>Blood donors</term>
<term>Blood phase</term>
<term>Blood products</term>
<term>Blood safety</term>
<term>Blood supply</term>
<term>Blood transfusion</term>
<term>Borna</term>
<term>Borrelia</term>
<term>Burgdorferi</term>
<term>Cervical</term>
<term>Chaga</term>
<term>Chan</term>
<term>Chikungunya</term>
<term>Chlamydia</term>
<term>Chronic carriage</term>
<term>Clade</term>
<term>Clin</term>
<term>Clin microbiol</term>
<term>Clinical disease</term>
<term>Crosse</term>
<term>Cruzi</term>
<term>Cutaneous</term>
<term>Deferral</term>
<term>Dengue</term>
<term>Derivative</term>
<term>Direct contact</term>
<term>Disease agent</term>
<term>Disease agent characteristics</term>
<term>Disease control</term>
<term>Disease name</term>
<term>Disease symptoms</term>
<term>Disinfectant</term>
<term>Donor</term>
<term>Donor deferral period</term>
<term>Doxycycline</term>
<term>Ebola</term>
<term>Ehrlichia</term>
<term>Emerg</term>
<term>Encephalitis</term>
<term>Encephalopathy</term>
<term>Endemic</term>
<term>Endemic areas</term>
<term>Engl</term>
<term>Enterocolitica</term>
<term>Enterovirus</term>
<term>Epidemiology</term>
<term>Exposure routes</term>
<term>Feces</term>
<term>Fields virology</term>
<term>Formaldehyde</term>
<term>Fractionation process</term>
<term>Fulminant</term>
<term>Genome</term>
<term>Genus</term>
<term>Glutaraldehyde</term>
<term>Hantavirus</term>
<term>Hantaviruses</term>
<term>Helical</term>
<term>Hemorrhagic</term>
<term>Hepatitis</term>
<term>Herpes</term>
<term>Herpesvirus</term>
<term>Howley</term>
<term>Human herpesvirus</term>
<term>Human infection</term>
<term>Hypochlorite</term>
<term>Icosahedral</term>
<term>Icosahedral nucleocapsid symmetry</term>
<term>Immune</term>
<term>Immunocompetent</term>
<term>Immunocompromised</term>
<term>Immunocompromised patients</term>
<term>Inactivating</term>
<term>Inactivation</term>
<term>Incubation</term>
<term>Incubation period</term>
<term>Infection</term>
<term>Infectious diseases</term>
<term>Infectivity</term>
<term>Intracellular</term>
<term>Isoform</term>
<term>Jama</term>
<term>June</term>
<term>Knipe</term>
<term>Lancet</term>
<term>Lassa</term>
<term>Leiby</term>
<term>Leishmania</term>
<term>Leishmaniasis</term>
<term>Length physicochemical properties</term>
<term>Leukoreduction</term>
<term>Lipid</term>
<term>Lipid solvents</term>
<term>Lippincott</term>
<term>Lippincott williams wilkins</term>
<term>Local deferral</term>
<term>Lyme</term>
<term>Lymphadenopathy</term>
<term>Marburg</term>
<term>Meningitis</term>
<term>Microbiol</term>
<term>Microti</term>
<term>Mmwr</term>
<term>Monkeypox</term>
<term>Morb</term>
<term>Mortality rate</term>
<term>Mosquito</term>
<term>Multiple pathogen reduction steps</term>
<term>Mumps</term>
<term>Myalgia</term>
<term>Neonate</term>
<term>Neurologic</term>
<term>Nonenveloped</term>
<term>Nonhuman</term>
<term>Nonhuman primates</term>
<term>Nucleic</term>
<term>Nucleic acid</term>
<term>Nucleocapsid</term>
<term>Orientia</term>
<term>Other prevention measures</term>
<term>Outbreak</term>
<term>Parasitemia</term>
<term>Parenteral</term>
<term>Parvovirus</term>
<term>Pathogen</term>
<term>Pathogen reduction</term>
<term>Peripheral blood</term>
<term>Phagocytophilum</term>
<term>Physicochemical</term>
<term>Physicochemical properties</term>
<term>Plasma derivatives</term>
<term>Plasmodium</term>
<term>Platelet</term>
<term>Pleomorphic</term>
<term>Pneumoniae</term>
<term>Porcine</term>
<term>Potential effectiveness</term>
<term>Primary disease symptoms</term>
<term>Primates</term>
<term>Prion</term>
<term>Priority level</term>
<term>Prowazekii</term>
<term>Prpc</term>
<term>Prpsc</term>
<term>Prudent practice</term>
<term>Public concern</term>
<term>Public perception</term>
<term>Raoult</term>
<term>Rash</term>
<term>Rbc</term>
<term>Reactivation</term>
<term>Relapsing</term>
<term>Retrovirus</term>
<term>Rickettsia</term>
<term>Rickettsial</term>
<term>Robust</term>
<term>Room temperature</term>
<term>Sars</term>
<term>Screening</term>
<term>Secondary transmission</term>
<term>Serologic</term>
<term>Serology</term>
<term>Seropositive</term>
<term>Seroprevalence</term>
<term>Simian</term>
<term>Sodium hypochlorite</term>
<term>Spherical particles</term>
<term>Spongiform</term>
<term>Supplement transfusion</term>
<term>Symptom</term>
<term>Tetracycline</term>
<term>Transfusion</term>
<term>Transfusion transmission</term>
<term>Transfusion volume</term>
<term>Transmission</term>
<term>Transplantation</term>
<term>Trypanosoma</term>
<term>Tsutsugamushi</term>
<term>Uids</term>
<term>Unknown impact</term>
<term>Unknown transmission</term>
<term>Vaccine</term>
<term>Vaccinia</term>
<term>Variola</term>
<term>Vcjd</term>
<term>Viii</term>
<term>Viral</term>
<term>Viremia</term>
<term>Viremic</term>
<term>Virion</term>
<term>Virol</term>
<term>Virology</term>
<term>Virus</term>
<term>Virus infection</term>
<term>Virus isolation</term>
<term>Whole blood</term>
<term>Wilkins</term>
<term>Wkly</term>
<term>Xenotransplantation</term>
<term>Yersinia</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list></list>
<tree></tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002E77 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002E77 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:162481915B7934FBCCFFD6340580113709AD18D5 |texte= APPENDIX 2 }}
This area was generated with Dilib version V0.6.33. |